ZFIN ID: ZDB-FISH-200507-65
Fish name: glo1zf3029/zf3029
Genotype: glo1zf3029/zf3029
Targeting Reagent: none
HUMAN DISEASE MODELED by glo1zf3029/zf3029
No data available
GENE EXPRESSION
Gene expression in glo1zf3029/zf3029
Reporter gene expression No data available
PHENOTYPE
Phenotype in glo1zf3029/zf3029
Phenotype Conditions Figures
blood glucose amount, normal fasting Fig. 5 from Lodd et al., 2019
blood glucose increased amount, abnormal increased food availability Fig. 6 from Lodd et al., 2019
blood glucose increased amount, abnormal food availability Fig. 5 from Lodd et al., 2019
eye methylglyoxal amount, normal increased food availability Fig. 8 from Lodd et al., 2019
eye methylglyoxal increased amount, abnormal food availability Fig. 8 from Lodd et al., 2019
fatty acid metabolic process process quality, abnormal standard conditions Fig. 4 from Lodd et al., 2019
glucose metabolic process delayed, abnormal food availability Fig. 5 from Lodd et al., 2019
liver ab6-rps6k labeling decreased amount, abnormal increased food availability Fig. 9 from Lodd et al., 2019
liver fatty, abnormal increased food availability Fig. 6 from Lodd et al., 2019
liver ab6-rps6k labeling increased amount, abnormal food availability Fig. 9 from Lodd et al., 2019
liver lipid droplet increased amount, abnormal increased food availability Fig. 6 from Lodd et al., 2019
skeletal muscle ab6-rps6k labeling increased amount, abnormal food availability Fig. 9 from Lodd et al., 2019
whole organism glo1 expression absent, abnormal standard conditions Fig. 1 from Lodd et al., 2019
whole organism aldh3a1 expression increased amount, abnormal standard conditions Fig. S3 from Lodd et al., 2019
whole organism aldh9a1a.2 expression increased amount, abnormal standard conditions Fig. S3 from Lodd et al., 2019
whole organism aldh9a1b expression increased amount, abnormal standard conditions Fig. S3 from Lodd et al., 2019
whole organism aldh3a2a expression increased amount, abnormal standard conditions Fig. S3 from Lodd et al., 2019
whole organism increased weight, abnormal increased food availability Fig. 6 from Lodd et al., 2019
whole organism morphology, normal standard conditions Fig. 1Fig. 5 from Lodd et al., 2019
whole organism size, normal standard conditions Fig. 5 from Lodd et al., 2019
whole organism aldo-keto reductase (NADP) activity process quality, normal standard conditions Fig. 3 from Lodd et al., 2019
whole organism lactoylglutathione lyase activity arrested, abnormal standard conditions Fig. 1 from Lodd et al., 2019
whole organism methylglyoxal increased amount, abnormal standard conditions Fig. 1Fig. 5 from Lodd et al., 2019
whole organism omega-3 fatty acid increased amount, abnormal standard conditions Fig. 4 from Lodd et al., 2019
whole organism omega-9 fatty acid increased amount, abnormal standard conditions Fig. 4 from Lodd et al., 2019
whole organism saturated fatty acid increased amount, abnormal standard conditions Fig. 4 from Lodd et al., 2019

CITATIONS  (1)